MI Cancer Seek™ is the first FDA-approved test combining whole exome and transcriptome sequencing for solid tumor molecular profiling. The test identifies patients for targeted therapies in breast, ...

My daughter's diagnosis of a rare and aggressive brain tumor at 3 years old made me strongly consider whether or not to have her treated with radiation.

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

Graft-versus-host disease prophylaxis using posttransplant cyclophosphamide remains a valid option for patients with ...

After cancer treatment, I wanted to go right back to living my life normally, but a fellow CURE blogger’s post reminded me ...

From James Van Der Beek spreading awareness about colorectal cancer at a younger age to Gerry Connolly’s recent esophageal ...

CURE partnered with City of Hope for a webinar to discuss focusing on quality of life when talking with care teams during ...

In this on-demand webinar series, CURE partnered with City of Hope to discuss effective communication when making treatment ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

Colorectal cancer incidence is rising among adults under 55, despite overall declining rates since the mid-1980s. Lifestyle ...

Emotional support from friends significantly enhances resilience during cancer treatment, providing comfort and strength.

In patients with relapsed or refractory multiple myeloma, KRd56 and KRd27 showed similar effectiveness and safety, but other treatment options may be better. Receiving the once-weekly KRd56 treatment ...